RefleXion Medical hikes up Series B funding to $52 mln
Hayward, California-based RefleXion Medical, which is developing a radiotherapy system for personalized cancer treatment, has increased its Series B funding to $52 million. KCK Group was the lead investor. Other investors included Venrock, Pfizer Venture Investments, Sofinnova Partners and Johnson & Johnson Innovation -- JJDC Inc.
19 July 2016•1 min read
